EPH50 Characterization of Clinical Features and Treatment of Non-Small Cell Lung Cancer (NSCLC) STAGE III and IV in Brazil- a Retrospective DATA-Base Study
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.803
https://www.valueinhealthjournal.com/article/S1098-3015(22)01004-X/fulltext
Title :
EPH50 Characterization of Clinical Features and Treatment of Non-Small Cell Lung Cancer (NSCLC) STAGE III and IV in Brazil- a Retrospective DATA-Base Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01004-X&doi=10.1016/j.jval.2022.04.803
First page :
Section Title :
Open access? :
No
Section Order :
10724